First biosciences company lists in Singapore
Wednesday, 23 March, 2005
Dutch company LMA International has become the first biosciences company to list on Singapore's stock exchange, raising S$248 million (AUD$194 million) through the an initial public offering by its Singapore unit, LMA International.
Shares in the company rose to S$0.95 cents on their first day of trading, a premium of 8 per cent on their issue price.
LMA International develops and markets medical equipment -- including a laryngeal mask and other airway management devices.
$780m Sydney Biomedical Accelerator gains its founding Executive Director
Professor Victoria Cogger has been appointed as founding Executive Director of the Sydney...
Portable point-of-care test detects four common STIs in under an hour
Australian researchers have developed a portable point-of-care test that detects four common...
AusBiotech and Proto Axiom partner on investor-focused life sciences programs
AusBiotech and Proto Axiom have announced a partnership to strengthen national coordination...
